5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Buy
78
XMTR Quote, Financials, Valuation and Earnings
Last price:
$30.56
Seasonality move
:
17.75%
Day range:
$30.01 - $31.63
52-week range:
$11.08 - $45.33
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.58x
P/B ratio:
4.90x
Volume:
790.1K
Avg. volume:
673K
1-year change:
82.73%
Market cap:
$1.5B
Revenue:
$545.5M
EPS (TTM):
-$0.99
Analysts' Opinion
-
Consensus RatingXometry has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 2 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $34.22, Xometry has an estimated upside of 14.27% from its current price of $29.95.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $20.00 representing 33.22% downside risk from its current price of $29.95.
Fair Value
-
According to the consensus of 7 analysts, Xometry has 14.27% upside to fair value with a price target of $34.22 per share.
XMTR vs. S&P 500
-
Over the past 5 trading days, Xometry has overperformed the S&P 500 by 17.96% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Xometry does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Xometry has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Xometry reported revenues of $151M.
Earnings Growth
-
Xometry has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Xometry reported earnings per share of -$0.30.
Enterprise value:
1.6B
EV / Invested capital:
2.64x
Price / LTM sales:
2.58x
EV / EBIT:
--
EV / Revenue:
2.74x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-59.11x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$224.1M
Return On Assets:
-7.15%
Net Income Margin (TTM):
-8.52%
Return On Equity:
-15.45%
Return On Invested Capital:
-8.15%
Operating Margin:
-10.2%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $402.6M | $480.8M | $573.8M | $122.7M | $151M | |
| Gross Profit | $152.4M | $186.8M | $224.1M | $47.9M | $56.3M | |
| Operating Income | -$77.1M | -$71.3M | -$53.6M | -$17.9M | -$15.4M | |
| EBITDA | -$63.2M | -$50.1M | -$30M | -$12.3M | -$9.6M | |
| Diluted EPS | -$1.56 | -$1.36 | -$0.99 | -$0.34 | -$0.30 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $73.6M | $423M | $372.8M | $341.4M | $334.6M | |
| Total Assets | $84.6M | $761.3M | $724.7M | $692.5M | $690.1M | |
| Current Liabilities | $43.3M | $53.8M | $64.8M | $78.7M | $89.4M | |
| Total Liabilities | $44.3M | $351.1M | $362.3M | $370.9M | $379.1M | |
| Total Equity | $40.3M | $410.2M | $362.4M | $321.6M | $311M | |
| Total Debt | $15.8M | $278.5M | $280.4M | $282.2M | $284.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$54.8M | -$25.2M | -$7.3M | -$11.7M | -$3.7M | |
| Cash From Investing | $33.8M | $29.7M | -$26.8M | $2.9M | -$3.7M | |
| Cash From Financing | $2M | $1.8M | $3.9M | $1.2M | $510K | |
| Free Cash Flow | -$70.1M | -$43.8M | -$26.6M | -$16.1M | -$9.2M | |
XMTR
Sector
Market Cap
$1.5B
$583M
Price % of 52-Week High
66.07%
73.62%
Dividend Yield
0%
0%
Shareholder Yield
--
2.42%
1-Year Price Total Return
82.73%
-8%
Beta (5-Year)
--
0.782
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$27.54
200-day SMA
Buy
Level
$25.77
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$24.55
Relative Strength Index (RSI14)
Buy
Level
69.05
ADX Line
Neutral
Level
0
Williams %R
Sell
Level
-15.3392
50-day SMA
Buy
Level
$24.86
MACD (12, 26)
Buy
Level
1.18
25-day Aroon Oscillator
Buy
Level
84
On Balance Volume
Neutral
Level
--
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.7585)
Sell
CA Score
(Annual)
Level (-0.6187)
Buy
Beneish M-Score
(Annual)
Level (-2.6583)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (1.0594)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.
Stock Forecast FAQ
In the current month, XMTR has received 4 Buy ratings 2 Hold ratings, and 1 Sell ratings. The XMTR average analyst price target in the past 3 months is $34.22.
-
Where Will Xometry Stock Be In 1 Year?
According to analysts, the consensus estimate is that Xometry share price will rise to $34.22 per share over the next 12 months.
-
What Do Analysts Say About Xometry?
Analysts are divided on their view about Xometry share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Xometry is a Sell and believe this share price will drop from its current level to $20.00.
-
What Is Xometry's Price Target?
The price target for Xometry over the next 1-year time period is forecast to be $34.22 according to 7 Wall Street analysts, 4 of them rate the stock a Buy, 1 rates the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is XMTR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Xometry is a Buy. 4 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of XMTR?
You can purchase shares of Xometry via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Xometry shares.
-
What Is The Xometry Share Price Today?
Xometry was last trading at $30.56 per share. This represents the most recent stock quote for Xometry. Yesterday, Xometry closed at $29.95 per share.
-
How To Buy Xometry Stock Online?
In order to purchase Xometry stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is BYD a Threat To Tesla Shareholders?
BYD (OTC:BYDDY) has rocketed to the top of China’s booming…
CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
99
DAVE alert for May 9
Dave [DAVE] is up 41.65% over the past day.
Buy
60
RGC alert for May 8
Regencell Bioscience Holdings [RGC] is up 10.54% over the past day.
Buy
92
TPB alert for May 8
Turning Point Brands [TPB] is down 6.67% over the past day.
